CN109303724A - 一种新型含艾叶的舒缓修护原液组合物 - Google Patents
一种新型含艾叶的舒缓修护原液组合物 Download PDFInfo
- Publication number
- CN109303724A CN109303724A CN201811256735.5A CN201811256735A CN109303724A CN 109303724 A CN109303724 A CN 109303724A CN 201811256735 A CN201811256735 A CN 201811256735A CN 109303724 A CN109303724 A CN 109303724A
- Authority
- CN
- China
- Prior art keywords
- skin
- folium artemisiae
- artemisiae argyi
- antiallergic
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 238000012423 maintenance Methods 0.000 title claims abstract description 19
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 43
- 239000004909 Moisturizer Substances 0.000 claims abstract description 6
- 230000001333 moisturizer Effects 0.000 claims abstract description 6
- 239000002562 thickening agent Substances 0.000 claims abstract description 3
- 239000000284 extract Substances 0.000 claims description 39
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 26
- -1 palmityl tetrapeptide -7 Chemical compound 0.000 claims description 11
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 10
- 238000009418 renovation Methods 0.000 claims description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 6
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 6
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 6
- 241001506047 Tremella Species 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 229960005323 phenoxyethanol Drugs 0.000 claims description 6
- 241000219357 Cactaceae Species 0.000 claims description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 5
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 229940101267 panthenol Drugs 0.000 claims description 5
- 235000020957 pantothenol Nutrition 0.000 claims description 5
- 239000011619 pantothenol Substances 0.000 claims description 5
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 5
- SCVVSSZVLZQUDZ-UHFFFAOYSA-N 3-methyl-2,6-dihydro-1H-pyrimidine-2-carboxylic acid Chemical compound CN1C(NCC=C1)C(=O)O SCVVSSZVLZQUDZ-UHFFFAOYSA-N 0.000 claims description 4
- 229960003237 betaine Drugs 0.000 claims description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 4
- OGNHOGPWQTWKGQ-VGWMRTNUSA-N (2S)-5-amino-2-[[(2S)-1-[2-[[(2S)-5-amino-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 OGNHOGPWQTWKGQ-VGWMRTNUSA-N 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 3
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 3
- 229960003415 propylparaben Drugs 0.000 claims description 3
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical group CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims 3
- 241000220317 Rosa Species 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 230000003266 anti-allergic effect Effects 0.000 abstract description 60
- 230000008439 repair process Effects 0.000 abstract description 45
- 208000003251 Pruritus Diseases 0.000 abstract description 22
- 201000004624 Dermatitis Diseases 0.000 abstract description 15
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 15
- 239000002537 cosmetic Substances 0.000 abstract description 14
- 239000003755 preservative agent Substances 0.000 abstract description 11
- 230000002335 preservative effect Effects 0.000 abstract description 11
- 230000001151 other effect Effects 0.000 abstract description 5
- 239000002131 composite material Substances 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 161
- 230000000694 effects Effects 0.000 description 48
- 239000000047 product Substances 0.000 description 37
- 238000003756 stirring Methods 0.000 description 33
- 239000002994 raw material Substances 0.000 description 25
- 238000005067 remediation Methods 0.000 description 25
- 238000002360 preparation method Methods 0.000 description 24
- 208000024891 symptom Diseases 0.000 description 16
- 239000000463 material Substances 0.000 description 14
- 241000205585 Aquilegia canadensis Species 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 230000006870 function Effects 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 235000011399 aloe vera Nutrition 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000010792 warming Methods 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- 241001116389 Aloe Species 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 244000170916 Paeonia officinalis Species 0.000 description 5
- 235000006484 Paeonia officinalis Nutrition 0.000 description 5
- 241000245665 Taraxacum Species 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000036555 skin type Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 244000144927 Aloe barbadensis Species 0.000 description 4
- 235000002961 Aloe barbadensis Nutrition 0.000 description 4
- 235000007516 Chrysanthemum Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000036592 analgesia Effects 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 240000005250 Chrysanthemum indicum Species 0.000 description 3
- 206010048768 Dermatosis Diseases 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000607764 Shigella dysenteriae Species 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 235000021321 essential mineral Nutrition 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
- FBYFHODQAUBIOO-UHFFFAOYSA-N 2-(1-carboxyethoxy)propanoic acid Chemical compound OC(=O)C(C)OC(C)C(O)=O FBYFHODQAUBIOO-UHFFFAOYSA-N 0.000 description 2
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- KAWOEDMUUFFXAM-UHFFFAOYSA-N CC1(C)CCCC2(C)C(C)C(C=O)=CCC21 Polymers CC1(C)CCCC2(C)C(C)C(C=O)=CCC21 KAWOEDMUUFFXAM-UHFFFAOYSA-N 0.000 description 2
- 240000001432 Calendula officinalis Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 2
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 244000042664 Matricaria chamomilla Species 0.000 description 2
- 235000004429 Matricaria chamomilla var recutita Nutrition 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 240000003889 Piper guineense Species 0.000 description 2
- AZJUJOFIHHNCSV-KCQAQPDRSA-N Polygodial Polymers C[C@@]1([C@H](C(C=O)=CC2)C=O)[C@@H]2C(C)(C)CCC1 AZJUJOFIHHNCSV-KCQAQPDRSA-N 0.000 description 2
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241001302463 Viola mandshurica Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000009285 allergic inflammation Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000000043 antiallergic agent Substances 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000008845 cholagoga Substances 0.000 description 2
- 229940124571 cholagogue Drugs 0.000 description 2
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N cholesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000001794 hormone therapy Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical class O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 2
- 229940033329 phytosphingosine Drugs 0.000 description 2
- FPGPDEPMWUWLOV-UHFFFAOYSA-N polygodial Natural products CC1(C)CCCC2(C)C(C=O)C(=CC(O)C12)C=O FPGPDEPMWUWLOV-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 229940007046 shigella dysenteriae Drugs 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229940083542 sodium Drugs 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- 206010000125 Abnormal dreams Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- XAFPURGXVZDMJH-LLVAEMQGSA-N CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO.CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO.CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO XAFPURGXVZDMJH-LLVAEMQGSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 235000008496 Drimys aromatica Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 235000016622 Filipendula ulmaria Nutrition 0.000 description 1
- 244000061544 Filipendula vulgaris Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 108010063907 Glutathione Reductase Proteins 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 240000007232 Illicium verum Species 0.000 description 1
- 235000008227 Illicium verum Nutrition 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 1
- 240000002262 Litsea cubeba Species 0.000 description 1
- 235000012854 Litsea cubeba Nutrition 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001287809 Nierembergia Species 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 241000287127 Passeridae Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 241001165494 Rhodiola Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004870 Styrax Substances 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 240000000377 Tussilago farfara Species 0.000 description 1
- 235000004869 Tussilago farfara Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003944 flavone Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000000215 hyperchromic effect Effects 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- QMHBZWNZCSNBGU-UHFFFAOYSA-N nonane-1,2,3-triol Chemical compound CCCCCCC(O)C(O)CO QMHBZWNZCSNBGU-UHFFFAOYSA-N 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000004330 tyrosol Nutrition 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种新型含艾叶的舒缓修护原液组合物，按重量百分比，其包含：抗敏舒缓剂0.1‑5.0％,皮肤修复剂0.1‑5.0％，防腐剂0.1％‑1.0％，保湿剂1‑15.0％，增稠剂4％‑10％。水：余量。本发明皮肤修护组合物可制成霜剂和水剂，直接涂于患处，对人体皮肤无毒无害。其中的皮肤舒缓修复复合成分具有很强的抗敏修复、消炎收敛等功效；其他辅佐添加组分均选用能使皮肤柔嫩、光滑、滋润且对皮肤温和无刺激的保湿剂、防腐剂等，使用方便，消炎止痒、修复受损皮肤的目的，适合敏感性皮肤以及化妆品使用不当引起的皮肤过敏、瘙痒、脱屑、红肿、等现象。
Description
技术领域
本发明涉及一种新型含艾叶的舒缓修护原液组合物，属化妆品配方技术领域。
背景技术
随着现代科技的进步，人们生活水平的提高，人们对于健康美丽的外表的追求越来越强烈，城市污染，工业废气，紫外线照射，不合格化妆品的使用以及各种美疗仪器的滥用也日益危害着我们的皮肤，据2004年统计显示，接触性皮炎在六大类化妆品皮肤病中最为常见,其发病率占化妆品皮肤病总发病率的82.6％。过敏似乎成了人们在追求健康美的道路上如影随形的噩梦。治疗敏感或过敏性皮肤多发的红斑、丘疹、脱屑、瘙痒等病症，需使用糖皮类激素；若长期反复使用激素，会出现皮肤萎缩，毛细血管扩张、紫癜、痤疮色素异常、光过敏等症状，给现代爱美的女性带来无尽的烦恼，且激素治疗易产生依赖性。如何找到安全有效的缓解过敏症状的方法，成为人们日益关注的问题。近年来化妆品行业正在逐渐朝着崇尚绿色、回归自然的方向发展。但大多数植物抗敏添加物疗效都不甚理想，开发含有独特功效的天然抗敏活性物质,并将其添加到化妆品中,研制天然安全有效抗敏产品,已成为化妆品产业发展最活跃的主题之一。
本发明针对敏感或受损皮肤多发性皮炎，施以抗敏消炎天然植物提取物，同时辅以其他组分原料，使配方中所含有效成分具有抗敏修复、收敛消炎、增加皮肤弹性和光泽等作用。该皮肤抗敏修复组合可直接作用于皮肤受损部位，相较于口服或注射性抗敏药物无毒副作用效果好，使用简单方便，能迅速缓解由于皮肤过敏引起的红肿疼痛，解决了广大爱美女性在化妆品使用过程中，皮肤过敏现象频繁产生的困扰，以及采用激素治疗过敏性皮肤炎症对患者造成的更大的皮肤损害问题。既适合于敏感性皮肤对于过敏症状的缓解和预防，又适合于由于化妆品使用不当引起的过敏症状。
发明内容
针对现有技术中存在的问题，本发明提供一种用于舒缓修复的植物原液及其制备方法，通过添加具有舒缓肌肤、抗刺激，减少面部发红、发痒，修护皮肤屏障，消除不舒适感，建立皮肤保护膜的皮肤舒缓修复组合物实现的。该发明中提及的皮肤舒缓组合物包括艾叶提取物、假八角叶提取物、红景天提取物、银耳提取物、扭刺仙人掌提取物、燕麦提取物。提及的皮肤修复组合物包括四氢甲基嘧啶羧酸、泛醇、棕榈酰四肽-7、三肽-1、六肽-9、棕榈酰五肽-4、棕榈酰三肽-1、棕榈酰三肽-5。该产品具有天然无刺激、舒缓修复效果明显持久等优点。
本发明是通过如下技术方案来实现上述目的的：一种艾叶舒缓修复原液组合物，其特征在于：它是由下列重量百分比的原料制成的：
本发明优选采用的皮肤修复剂是四氢甲基嘧啶羧酸、泛醇、棕榈酰四肽 -7、三肽-1、六肽-9、棕榈酰五肽-4、棕榈酰三肽-1、棕榈酰三肽-5
四氢甲基嘧啶羧酸是利用生物发酵技术从天然微生物中获得的一种小分子氨基酸衍生物。会束缚周围水分子形成复合体，包裹在细胞、酶、蛋白质和其他有机分子周围，形成具有保护滋养和稳定水合作用的保护壳，从而防止细胞损伤。
泛醇即维生素原B5，是应用较广泛的维生素B类营养补充剂，广泛应用在医药、食品、饲料、化妆品等领域，皮肤药剂类、护肤、毛发类化妆品较广泛应用。泛醇的分子量较小，能够有效渗透角质层，浸润肌肤表面的角质层，具有强效的保湿效果，有效改善肌肤粗糙，使肌肤柔软，能够刺激上皮细胞生长，加速表皮伤口愈合时间，修复组织创伤。
修复肽含多种高浓度生物活性肽，由表及里，强效修复，肌肤年轻化。促进角蛋白合成，提高表皮的再生能力，修复皮肤屏障；促进基底膜关键蛋白生成，加固BMZ，维持皮肤弹性；多靶点激活成纤维母细胞，生成胶原蛋白、弹性蛋白、多糖等，强效修复，去皱抗衰。
本发明优选采用的皮肤舒缓组合物包括艾叶提取物、假八角叶提取物、玫瑰红景天提取物、银耳提取物、扭刺仙人掌提取物、燕麦提取物。
艾叶有艾以叶入药，性温、味苦、无毒、纯阳之性、通十二经、具回阳、理气血、逐湿寒、止血安胎等功效，亦常用于针灸。故又被称为“医草”，中国台湾地区正流行的“药草浴”，大多就是选用艾草。关于艾叶的性能，《本草》载：“艾叶能灸百病。”
假八角叶源自澳洲东南部地区的珍稀植物胡椒莓，生长在塔斯马尼亚山海拔1400米以上严寒地带。俗称阿尔派尼胡椒、高山胡椒、黑紫色小浆果。强效抗炎剂，迅速缓解并镇静敏感性皮肤的刺痛感和灼热感。主要含有组分：水蓼二醛、花青苷、芸香苷、必需矿物质镁、必需矿物质锌。其中水蓼二醛是一种多功能天然活性成分，具有抗炎功效，能够舒缓皮肤不适感，花青苷具有对抗自由基，强大的抗氧化功效；芸香苷能够帮助反应性肌肤镇静；必需矿物质镁刺激细胞更新，增强能量再生，锌减少红肿并缓解痤疮引起的炎症反应。
红景天提取物提取自生长在海拔800-2500米的高寒地区的库页红景天因其生长环境极度恶劣，机体中积累了大量抗氧化、抗辐射的次生代谢物质，其作用强度是补益中草药中罕见的。含有的红景天苷和苷元酪醇具有抗氧化的功效，可延缓细胞衰老，生长在高寒和强紫外线照射地域，具有抗微波，紫外线辐射，保湿功能。
菌中之冠的银耳，含有丰富的蛋白质和多种氨基酸，人体所必须的氨基酸中四分之三银耳都能提供。银耳含有海藻糖、多缩戊糖、甘露糖醇，对皮肤提供充足的水分。富有天然植物性胶质，对皮肤有良好的保护及锁水作用。可持续为肌肤表层储存大量水分，持续补水，舒缓镇静肌肤。
仙人掌是沙漠常青树，主要含仙人掌多糖，B-谷甾醇等。极大地补充肌肤水分及缓和外界对肌肤的刺激。仙人掌多糖具有较强的清除自由基的能力，可延缓皮肤衰老，减少皱纹的产生。仙人掌具有抗菌性，对谷胱甘肽还原酶有活化作用，从而活化肌肤、舒缓皮肤刺激。
燕麦有植物黄金的美誉。含燕麦蛋白、燕麦肽，小分子活性成分，易吸收，及时补水，保湿舒缓肌肤。能够紧致肌肤，淡化细纹，改善皮肤纹理度。
所述的艾叶舒缓修复原液的制备方法，步骤如下：
(1)将甘油、丁二醇、1,3-丙二醇和透明质酸钠预先混合均匀备用；
(2)将去离子水加入搅拌锅中，搅拌下开始升温，把步骤(1)所得物料加入搅拌锅中，搅拌升温至85℃，保温30分钟，开始降温，加入对羟基苯乙酮搅拌均匀。
(3)降温到45℃下，搅拌下依次加入各种舒缓修复剂以及1,2-己二醇，甜菜碱搅拌均匀；
(4)降至室温，静置，检验；
(5)检验合格，200目过滤出料。
本发明的有益效果：本发明的有益效果是通过添加有效的修复镇静剂快速褪红止痒，同时辅以多种植物提取物持久调理，由内而外，彻底解决肌肤敏感受损状态。同时添加的多种物质均是天然安全来源，对肌肤没有副作用。
具体实施方式
以下结合实施例对本发明做进一步说明，实施例中的百分比均为重量百分比。
实施例1
制备含有1.0％皮肤抗敏修复组合物的皮肤修复原液
1、皮肤修复组合物的制备：取10克去离子水升温至85℃杀菌，降温到45℃后加入1克皮肤修复剂、1克抗敏舒缓剂、防腐剂，搅拌均匀，即得本发明皮肤抗敏修复组合物。
2、含1.0％皮肤修复剂的皮肤修复原液的制备方法
该舒缓修复原液的制备工艺如下：
(1)首先按上述表格中的原料名称和原料重量秤取各原料；
(2)将A相四种原料加热至85℃，搅拌至完全溶解；
(3)搅拌降温至70℃，将B相加入，搅拌均匀。
(4)搅拌降温至45℃，将C相加入，搅拌均匀。
(5)分装后即为成品。
实施例2
含2％皮肤修复剂的皮肤修复原液的制备方法
1、皮肤修复组合物的制备：取10克去离子水升温至85℃杀菌，降温到45℃后加入1克皮肤修复剂、1克抗敏舒缓剂、防腐剂，搅拌均匀，即得本发明皮肤抗敏修复组合物。
2、含2％皮肤抗敏修复组合物的舒缓修复原液的制备方法
该舒缓修复原液的制备工艺如下：
(1)首先按上述表格中的原料名称和原料重量秤取各原料；
(2)将A相四种原料加热至85℃，搅拌至完全溶解；
(3)搅拌降温至70℃，将B相加入，搅拌均匀。
(4)搅拌降温至45℃，将C相加入，搅拌均匀。
(5)分装后即为成品。
实施例3
含3％皮肤修复剂的皮肤修复原液的制备方法
1、皮肤修复组合物的制备：取10克去离子水升温至85℃杀菌，降温到45℃后加入1克皮肤修复剂、1克抗敏舒缓剂、防腐剂，搅拌均匀，即得本发明皮肤抗敏修复组合物。
2、含3％皮肤抗敏修复组合物的舒缓修复原液的制备方法
该皮肤修复霜的制备工艺如下：
(1)首先按上述表格中的原料名称和原料重量秤取各原料；
(2)将A相四种原料加热至85℃，搅拌至完全溶解；
(3)搅拌降温至70℃，将B相加入，搅拌均匀。
(4)搅拌降温至45℃，将C相加入，搅拌均匀。
(5)分装后即为成品。
实施例4
为表明本发明缓解皮肤过敏症状或过敏炎症的效果，本发明经过135名试用人员的观察和记录，其数据如下：
(1)135名试用人员年龄在20～35岁之间，按其皮肤敏感程度由弱到强的顺序分别把她们分为三种皮肤类型，其中54名试用者在日常皮肤护理过程中会偶尔出现面部轻微潮红、灼热、瘙痒等现象，为A型皮肤；36名试用者在日常使用护肤品时会经常出现面部潮红、瘙痒、灼热、干燥、脱屑现象，为B型皮肤；45名试用者为已经出现严重面部潮红、瘙痒、疼痛、干燥脱屑等症状，为C型皮肤。将上述每一种敏感皮肤类型平均分为3组，Ⅰ组使用添加0.5％的皮肤抗敏修组合物复剂产品，即按照实施例1所制备的产品；Ⅱ组使用添加1％的皮肤抗敏修组合物复剂的产品，即按照实施例2 所制备的产品；Ⅲ组使用添加2.0％的皮肤修抗敏复组合物复剂的产品，即按照实施例3所制备的产品。
(2)使用方法：取本发明成品，清洁患部，早晚各一次，持续使用一个月。
(3)效果判断标准：
痊愈或效果明显：自觉症状全部消失或大部分消失；
有效：自觉症状减轻或部分症状消失；
无效：自觉症状无改变，或改变不明显。
(6)试用结果如下：
表1 Ⅰ组使用添加1.0％的皮肤抗敏修复组合物产品对皮肤的影响
表2 Ⅱ组使用添加2.0％的皮肤抗敏修复组合物产品对皮肤的影响
表3 Ⅲ组使用添加3.0％的皮肤抗敏修复组合物产品对皮肤的影响
说明：显效率为试用人员中痊愈或效果显著的人数，占该种皮肤类型人数总数的百分比。
从上表所示可以看出，表1中添加1.0％皮肤抗敏修复组合物的产品对 A、B型皮肤的显效率都超过70％。对C型皮肤的显效率为53.3％，从以上结果可以看出，本发明对预防因护肤品使用引发的皮肤潮红、瘙痒、脱屑、干燥等现象效果明显，对中度过敏也有一定效果。
表2中使用添加2.0％的皮肤抗敏修复组合物对C型皮肤的显效率为 73.3％，对A、B型皮肤的显效率分别为88.9％、88.3％，对比表1中数据可以看出，使用添加1.0％的皮肤抗敏修复剂对A、B、C三种类型皮肤的显效率都有显著提升，对预防和缓解皮肤潮红、瘙痒、脱屑、干燥等现象效果显著。
表3中使用添加3.0％的皮肤抗敏修复组合剂对C型皮肤的显效率为 93.3％，对A、B型皮肤的显效率分别为94.4％、91.7％，对比表1、表2中数据可以看出，使用添加2.0％的皮肤抗敏修复组合剂产品对A、B、C三种类型皮肤的显效率都有显著提升，对预防和缓解皮肤潮红、瘙痒、脱屑、干燥等现象效果显著。
结论1：本发明皮肤修复剂对预防和缓解皮肤过敏引起的红肿、瘙痒、脱屑、干燥等现象效果显著。
结论2：含3.0％的皮肤修复组合物的皮肤抗敏修护霜的显效率远远高含1.0％的皮肤修复组合物。
滤得到粗滤液，去除可分辨大颗粒物质至半透明状液体，将粗滤液在 50℃条件下进行真空浓缩，浓缩至无乙醇，将浓缩液利用微孔膜进行精滤得到精滤液，在精滤液中加入精滤液质量10％的丙二醇，最后进行高温灭菌，得金盏花提取液；丙二醇一方面作为乙醇的替换溶剂，另一方面是为了稳定水溶液体系，纯水溶液易浑；
所述的控油祛痘的植物原液的制备方法，步骤如下：
(1)将甘油、黄原胶和透明质酸钠预先混合均匀备用；
(2)将1,3-丙二醇和乙基己基甘油预先混合均匀备用；
(3)将去离子水加入搅拌锅中，搅拌下开始升温，把步骤(1)所得物料加入搅拌锅中，搅拌升温至85℃，保温30分钟，开始降温，降温到45℃下，搅拌下依次加入步骤(2)制得的物料以及金盏花提取物、绣线菊提取物、莲籽提取物、苯氧乙醇搅拌均匀；
(4)降至室温，静置，检验；
(5)检验合格，200目过滤出料。
本发明的有益效果：本发明的有益效果是通过添加植物提取物获得的。绣线菊提取物能够有效抑制5α-还原酶活性，抑制皮肤腺体的分泌活性，防止脂溢和粉刺，同时抑菌成分，能够抑制形成粉刺的细菌。莲籽提取物能够有效分解暗疮、粉刺、调节油脂分泌；金盏花提取物具有超强的愈和能力，镇定肌肤，达到褪红、舒缓、修复之功效。三者配合使用能够有效地控制皮脂腺的分泌，分解暗疮并具有一定的皮肤修复功效。实验结果表明，三种提取物配合使用，能够获得最佳的使用效果。
本发明是通过如下技术方案来实现上述目的的：
一种新型皮肤抗敏修护组合物，其特征在于：它是由下列重量百分比的原料制成的：
所述的一种新型皮肤抗敏修护组合物，其特征在于：所述皮肤修复剂为：神经酰胺3，神经酰胺6II、神经酰胺1、胆甾醇、植物鞘氨醇、月桂酰乳酰乳酸钠、卡波姆、黄原胶。
所述的抗敏舒缓剂为水，甘油，母菊花提取物，欧锦葵花提取物，芍药根提取物，忍冬花提取物，欧蒲公英根茎/根提取物，紫花地丁提取物，苯氧乙醇，乙基己基甘油，库拉索芦荟叶汁。
所述的一种新型皮肤抗敏修护组合物，其特征在于：所诉防腐剂为：苯氧乙醇、乙基己基甘油、羟苯甲酯、羟苯丙酯、辛酰羟肟酸中的一种或几种。
所述的保湿剂为甘油、丙二醇、丁二醇、1,3丙二醇、甜菜碱、透明质酸钠中的一种或几种。
所述的一种新型皮肤抗敏修护组合物，其特征在于：主要功效原料为皮肤修复剂和抗敏舒缓剂本发明优选采用的抗敏舒缓剂为：水，甘油，母菊花提取物，欧锦葵花提取物，芍药根提取物，忍冬花提取物，欧蒲公英根茎/ 根提取物，紫花地丁提取物，苯氧乙醇，乙基己基甘油，库拉索芦荟叶汁。
组方剖析：
本发明是基于中医辩证学原理，针对敏感或受损皮肤多发皮炎施以抗敏消炎中药组合提取物，同时辅以其他组分原料，使制剂具有清热解毒，消炎杀菌，收敛修复、增强肌肤抵抗力，提高皮肤的弹性和光泽等作用。其中母菊花清热解毒，疏风平肝，菊花水剂可抑制金葡菌、大肠杆菌、痢疾杆菌等一般致病菌，具有很好的杀菌消炎的作用。欧锦葵含丰富的黏质液，具有祛痰、止咳、镇痛、消炎的功能。芍药根是我国传统中药，其根鲜脆多汁，具有镇痉、镇痛、通经作用。忍冬花又名金银花，金银花自古被誉为清热解毒的良药。它性甘寒气芳香，甘寒清热而不伤胃，芳香透达又可祛邪。金银花既能宣散风热，还善清解血毒，用于各种热性病，如身热、发疹、发斑、热毒疮痈、咽喉肿痛等症，均效果显著。欧蒲公英，甘，微苦，寒，具有改善湿疹、舒缓皮肤炎的功效。紫花地丁具有清热解毒，凉血消肿，清热利湿的作用，主治疔疮，痈肿，库拉索芦荟含芦荟多糖和维生素对人体的皮肤有良好的营养，不仅有解毒、消炎、再生新细胞的作用，还能增加因放射治疗而减少的白血球。丰富的本草营养，促进受损血管神经细胞的生长和修复，恢复皮下毛细血管细胞活力，起到美容护肤的作用。
本发明优选采用的皮肤修复剂是神经酰胺3，神经酰胺6II、神经酰胺 1、胆甾醇、植物鞘氨醇、月桂酰乳酰乳酸钠、卡波姆、黄原胶。
神经酰胺又称神经鞘脂类，是存在于人体皮肤最外侧的角质层细胞间类脂体的主要构成成分(>50％)起着防止水分散发及对外部刺激有防护功能的重要作用，承担着保护皮肤和滋润、保湿功能。也有许多研究报告指出，可以通过使用含神经酰胺的外用膏类产品，达到防止过敏性皮肤病的目的和抑制黑色素褐斑的效果。
胆甾醇又名胆固醇，胆固醇是动物组织细胞所不可缺少的重要物质，它不仅参与形成细胞膜，而且是合成胆汁酸，维生素D以及甾体激素的原料。胆固醇经代谢还能转化为胆汁酸、类固醇激素、7-脱氢胆固醇，并且7-脱氢胆固醇经紫外线照射就会转变为维生素D3。
植物鞘氨醇(PHYTOSPHINGOSINE)属于皮肤自身成分，是组成皮肤角质层锁水屏障的脂质来源，是维持皮肤天然防御功能的关键物质。该物质天然无刺激，为广谱的皮肤病学活性微粒及天然炎症调节剂，可缓和各种炎性因子对皮肤的刺激。
本发明的防腐剂优选是苯氧乙醇、乙基己基甘油、羟苯甲酯、羟苯丙酯、辛酰羟肟酸、对羟基苯乙酮中的一种或几种。
本发明的保湿剂为甘油、丙二醇、丁二醇、1,3丙二醇、甜菜碱、透明质酸钠中的一种或几种。
上述所有组分配伍后具有清热、解毒、凉血的协同的作用，能消除皮肤炎症，收敛滋润，光泽皮肤，修复受损部位，恢复肌肤的弹性和光泽。既能清散痈肿、洁肤增色，又能滋养保护皮肤，适合化妆品使用不当所引起的皮肤过敏、瘙痒、脱屑、红肿等皮肤类型。
本发明上述的原料组分中，植物提取物的药性特点及功效如下:
母菊花清热解毒，疏风平肝，降血压。菊花含多种有挥发油、黄酮类、胆碱、氨基酸、菊甙、绿原酸、维生素A和B族维生素、腺嘌呤、微量元素硒、镍、锰等，具有明显的抗病毒作用。菊花水剂可抑制金葡菌、大肠杆菌、痢疾杆菌等一般致病菌，且对异淤肼、链霉素和氨基水杨酸钠耐药或敏感的结核杆菌以及卡介苗也均有明显的抑菌作用。
欧锦葵含丰富的黏质液，具有祛痰、止咳、镇痛、消炎的功能，对喉痛声哑、支气管炎、呼吸道过敏待疾病颇有疗效，因此又别名"舒胸的花"。外敷则能减轻蜂叮、烫伤等造成的疼痛。
芍药的根仍称为“芍药”，是著名的中药材。早在一千多年前的医药著作《本草纲目》里，已有芍药的名称记载。芍药根的主要化学成分是芍药甙，此外还含有牡丹酚、安息香酸、挥发油、树脂、鞣质、糖类、淀粉、三萜类成分等。芍药甙对中枢神经有抑制作用，并有较好的解痉、镇痛、镇静、解热、抗惊厥、抗炎、抗溃疡、扩张冠状动脉及后肢血管、降血压等药理作用。
忍冬花，又名金银花。"金银花"一名出自《本草纲目》。金银花自古以来就以它的药用价值广泛而著名。《神农本草经》载：“金银花性寒味甘，具有清热解毒、凉血化淤之功效，主治外感风热、瘟病初起、疮疡疔毒、红肿热痛、便脓血”等。《本草纲目》中详细论述了金银花具有“久服轻身、延年益寿”的功效。二十世纪八十年代，国家卫生部对金银花先后进行了化学分析，结果表明：金银花含有多种人体必须的微量元素和化学成分，同时含有多种对人体有利的活性酶物质，具有抗衰老，防癌变，轻身健体的良好功效。金银花含环己六醇、黄酮类、肌醇、皂甙及鞣质等，具有广谱的抗菌作用，对金黄色萄球菌、痢疾杆菌等多种致病菌均有较强的抑制作用，对钩端螺旋体、流感病毒以及致病霉菌等多种病原微生物亦有抑制作用。
蒲公英属菊科属多年生草本植物。据《本草纲目》记载，它性平味甘微苦，有清热解毒、消肿散结作用。无论煎汁口服，还是捣泥外敷，皆有效验。此外，蒲公英还有利尿、缓泻、退黄疸、利胆等功效，被广泛应用于临床。《本草纲目》有云：“蒲公英嫩苗可食，生食治感染性疾病尤佳。”《神农本草经》、《唐本草》、《中药大辞典》等历代医学专著均给以高度评价。公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分，有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等，有丰富的营养价值。其中含有的胡萝卜素和C及矿物质，对消化不良、便秘都有改善的作用。另外叶子还有改善湿疹、舒缓皮肤炎的功效，根则具有消炎作用，花朵煎成药汁可以去除雀斑。
紫花地丁味苦、辛、寒。全草含甙类、黄酮类、蜡、蜡酸Cerotic acid 及不饱和酸等的酯类。能抑制结核杆菌，此外尚有清热，清肿，消炎等作用。
库拉索芦荟俗称药用芦荟，味苦、性寒。芦荟因其苦寒清热具有抑制过度的免疫反应增强吞噬细胞吞噬功能的作用故能清除体内代谢废物。芦荟中的aloetinalomicin等成分具有促进肝脏分解体内有害物质的作用，还能消除生物体外部侵入的毒素。放射线或核放射能治疗癌症过程中会引起的烧伤性皮肤溃疡，有芦荟治疗不仅有解毒、消炎、再生新细胞的作用，还能增加因放射治疗而减少的白血球。芦荟的缓激肽酶与血管紧张来联合可抵抗炎症。尤其是芦荟的多糖类可增强人体对疾病的抵抗力，治愈皮肤炎、慢性肾炎、膀胱炎、支气管炎等慢性病症。
本发明的有益效果在于：
本发明皮肤抗敏修护组合物可制成霜剂和水剂，直接涂抹于患处，对人体皮肤无毒无害。其中的皮肤修复复合成分具有很强的清热解毒、抗敏修复、消炎收敛等功效；其他辅佐添加组分均选用能使皮肤柔嫩、光滑、滋润且对皮肤温的保湿剂、防腐剂、增稠剂等，使用简单方便，达到保湿滋润、消炎止痒、修复受损皮肤的目的。本发明皮肤抗敏修护组合物适合敏感性皮肤以及化妆品使用不当引起的皮肤过敏、瘙痒、脱屑、红肿等现象。
以下结合实施例对本发明做进一步说明，实施例中的百分比均为重量百分比。
实施例1
制备含有0.5％皮肤抗敏修复组合物的皮肤修复霜
1、皮肤修复组合物的制备：取余量的水升温至90℃杀菌，降温到45℃后加入皮肤修复剂、抗敏舒缓剂、防腐剂，搅拌均匀，即得本发明皮肤抗敏修复组合物。
3、含0.5％皮肤修复剂的皮肤修复霜的制备方法
该皮肤修复霜的制备工艺如下：
(7)首先按上述表格中的原料名称和原料重量秤取各原料；
(8)将A相四种原料加热至85℃，搅拌至完全溶解；
(9)搅拌降温至50℃～60℃，将B相加入，搅拌并高速均质3min,搅拌降温至45℃，加入C相，搅拌均匀，降温至38℃即可得到目标产品。
(10)分装后即为成品。
实施例2
制备含有1％皮肤抗敏修复组合物的皮肤修复霜
1、皮肤修复组合物的制备：取余量的水升温至90℃杀菌，降温到45℃后加入皮肤修复剂、抗敏舒缓剂、防腐剂，搅拌均匀，即得本发明皮肤抗敏修复组合物。
2、含1％皮肤抗敏修复组合物的皮肤修复霜的制备方法
该皮肤修复霜的制备工艺如下：
(1)首先按上述表格中的原料名称和原料重量秤取各原料；
(2)将A相四种原料加热至85℃，搅拌至完全溶解；
(3)搅拌降温至50℃～60℃，将B相加入，搅拌并高速均质3min,搅拌降温至45℃，加入C相，搅拌均匀，降温至38℃即可得到目标产品。
(4)分装后即为成品。
实施例3
制备含有2％皮肤抗敏修复组合物的皮肤修复霜
1、皮肤修复组合物的制备：取余量的水升温至90℃杀菌，降温到45℃后加入皮肤修复剂、抗敏舒缓剂、防腐剂，搅拌均匀，即得本发明皮肤抗敏修复组合物。
2、含2％皮肤抗敏修复组合物的皮肤修复霜的制备方法
该皮肤修复霜的制备工艺如下：
(1)首先按上述表格中的原料名称和原料重量秤取各原料；
(2)将A相四种原料加热至85℃，搅拌至完全溶解；
(3)搅拌降温至50℃～60℃，将B相加入，搅拌并高速均质3min,搅拌降温至45℃，加入C相，搅拌均匀，降温至38℃即可得到目标产品。
(4)分装后即为成品。
实施例4
为表明本发明缓解皮肤过敏症状或过敏炎症的效果，本发明经过135名试用人员的观察和记录，其数据如下：
(1)135名试用人员年龄在20～35岁之间，按其皮肤敏感程度由弱到强的顺序分别把她们分为三种皮肤类型，其中54名试用者在日常皮肤护理过程中会偶尔出现面部轻微潮红、灼热、瘙痒等现象，为A型皮肤；36名试用者在日常使用护肤品时会经常出现面部潮红、瘙痒、灼热、干燥、脱屑现象，为B型皮肤；45名试用者为已经出现严重面部潮红、瘙痒、疼痛、干燥脱屑等症状，为C型皮肤。将上述每一种敏感皮肤类型平均分为3组，Ⅰ组使用添加0.5％的皮肤抗敏修组合物复剂产品，即按照实施例1所制备的产品；Ⅱ组使用添加1％的皮肤抗敏修组合物复剂的产品，即按照实施例2 所制备的产品；Ⅲ组使用添加2.0％的皮肤修抗敏复组合物复剂的产品，即按照实施例3所制备的产品。
(2)使用方法：取本发明成品，清洁患部，早晚各一次，持续使用一个月。
(3)效果判断标准：
痊愈或效果明显：自觉症状全部消失或大部分消失；
有效：自觉症状减轻或部分症状消失；
无效：自觉症状无改变，或改变不明显。
(11)试用结果如下：
表1 Ⅰ组使用添加0.5％的皮肤抗敏修复组合物产品对皮肤的影响
表2 Ⅱ组使用添加1.0％的皮肤抗敏修复组合物产品对皮肤的影响
表3 Ⅲ组使用添加2.0％的皮肤抗敏修复组合物产品对皮肤的影响
说明：显效率为试用人员中痊愈或效果显著的人数，占该种皮肤类型人数总数的
百分比。
从上表所示可以看出，表1中添加0.5％皮肤抗敏修复组合物的产品对 A、B型皮肤的显效率都超过70％。对C型皮肤的显效率为53.3％，从以上结果可以看出，本发明对预防因护肤品使用引发的皮肤潮红、瘙痒、脱屑、干燥等现象效果明显，对中度过敏也有一定效果。
表2中使用添加1.0％的皮肤抗敏修复组合物对C型皮肤的显效率为 73.3％，对A、B型皮肤的显效率分别为88.9％、88.3％，对比表1中数据可以看出，使用添加1.0％的皮肤抗敏修复剂对A、B、C三种类型皮肤的显效率都有显著提升，对预防和缓解皮肤潮红、瘙痒、脱屑、干燥等现象效果显著。
表3中使用添加2.0％的皮肤抗敏修复组合剂对C型皮肤的显效率为 93.3％，对A、B型皮肤的显效率分别为94.4％、91.7％，对比表1、表2中数据可以看出，使用添加2.0％的皮肤抗敏修复组合剂产品对A、B、C三种类型皮肤的显效率都有显著提升，对预防和缓解皮肤潮红、瘙痒、脱屑、干燥等现象效果显著。
结论1：本发明皮肤修复剂对预防和缓解皮肤过敏引起的红肿、瘙痒、脱屑、干燥等现象效果显著。
结论2：含2.0％的皮肤修复组合物的皮肤抗敏修护霜的显效率远远高含0.5％的皮肤修复组合物。
Claims (6)
1.一种新型含艾叶的舒缓修护原液组合物，其特征在于：按重量百分比，其包含：
2.根据权利要求1所述的一种新型含艾叶的舒缓修护原液组合物，其特征在于：所述皮肤修复剂为：四氢甲基嘧啶羧酸、泛醇、棕榈酰四肽-7、三肽-1、六肽-9、棕榈酰五肽-4、棕榈酰三肽-1、棕榈酰三肽-5。
3.根据权利要求1所述的一种新型含艾叶的舒缓修护原液组合物，其特征在于：所述防腐剂为：苯氧乙醇、乙基己基甘油、羟苯甲酯、羟苯丙酯、辛酰羟肟酸、对羟基苯乙酮中的一种或几种。
4.根据权利要求1所述的一种新型含艾叶的舒缓修护原液组合物，其特征在于：所述皮肤舒缓剂是艾叶提取物、假八角叶提取物、玫瑰红景天提取物、银耳提取物、扭刺仙人掌提取物、燕麦提取物。
5.根据权利要求1所述的一种新型含艾叶的舒缓修护原液组合物，其特征在于：保湿剂为甘油、丁二醇、1,3丙二醇、透明质酸钠、甜菜碱、生物糖胶-1中的一种或几种。
6.根据权利要求1所述的一种新型含艾叶的舒缓修护原液组合物，其特征在于：增稠剂为甘油、甘油聚丙烯酸酯。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811256735.5A CN109303724A (zh) | 2018-10-26 | 2018-10-26 | 一种新型含艾叶的舒缓修护原液组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811256735.5A CN109303724A (zh) | 2018-10-26 | 2018-10-26 | 一种新型含艾叶的舒缓修护原液组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109303724A true CN109303724A (zh) | 2019-02-05 |
Family
ID=65222093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811256735.5A Pending CN109303724A (zh) | 2018-10-26 | 2018-10-26 | 一种新型含艾叶的舒缓修护原液组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109303724A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110664640A (zh) * | 2019-10-17 | 2020-01-10 | 张军 | 一种植物精华美白祛痘精华液及其制备方法 |
| CN111529463A (zh) * | 2020-05-15 | 2020-08-14 | 广州比力福生物科技有限公司 | 一种复方植物抗敏剂 |
| CN112006960A (zh) * | 2020-09-15 | 2020-12-01 | 广州莱约生物科技有限公司 | 祛痘控油组合物及其制备方法及其应用 |
| CN119033659A (zh) * | 2024-08-29 | 2024-11-29 | 澳思美日用化工（广州）有限公司 | 一种适用于敏感肌的美白组合物、用途和化妆品 |
| WO2025156457A1 (zh) * | 2024-01-25 | 2025-07-31 | 深圳摩尔雾化健康医疗科技有限公司 | 护肤活性物、护肤品 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106074315A (zh) * | 2016-08-24 | 2016-11-09 | 广东芭薇生物科技股份有限公司 | 一种具有多重护肤功效的面膜液及其制备方法 |
| CN106963660A (zh) * | 2017-04-06 | 2017-07-21 | 湖南御家化妆品制造有限公司 | 一种皮肤修复保湿组合物及其在制备化妆品中的应用 |
| CN107714594A (zh) * | 2017-12-11 | 2018-02-23 | 方政 | 一种敏感肌肤舒缓液及其制备工艺 |
-
2018
- 2018-10-26 CN CN201811256735.5A patent/CN109303724A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106074315A (zh) * | 2016-08-24 | 2016-11-09 | 广东芭薇生物科技股份有限公司 | 一种具有多重护肤功效的面膜液及其制备方法 |
| CN106963660A (zh) * | 2017-04-06 | 2017-07-21 | 湖南御家化妆品制造有限公司 | 一种皮肤修复保湿组合物及其在制备化妆品中的应用 |
| CN107714594A (zh) * | 2017-12-11 | 2018-02-23 | 方政 | 一种敏感肌肤舒缓液及其制备工艺 |
Non-Patent Citations (2)
| Title |
|---|
| 武谦虎: "《美容食物一本通》", 31 October 2013 * |
| 王建新: "《化妆品植物原料大全》", 30 June 2012 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110664640A (zh) * | 2019-10-17 | 2020-01-10 | 张军 | 一种植物精华美白祛痘精华液及其制备方法 |
| CN111529463A (zh) * | 2020-05-15 | 2020-08-14 | 广州比力福生物科技有限公司 | 一种复方植物抗敏剂 |
| CN112006960A (zh) * | 2020-09-15 | 2020-12-01 | 广州莱约生物科技有限公司 | 祛痘控油组合物及其制备方法及其应用 |
| WO2025156457A1 (zh) * | 2024-01-25 | 2025-07-31 | 深圳摩尔雾化健康医疗科技有限公司 | 护肤活性物、护肤品 |
| CN119033659A (zh) * | 2024-08-29 | 2024-11-29 | 澳思美日用化工（广州）有限公司 | 一种适用于敏感肌的美白组合物、用途和化妆品 |
| CN119033659B (zh) * | 2024-08-29 | 2025-07-04 | 澳思美日用化工（广州）有限公司 | 一种适用于敏感肌的美白组合物、用途和化妆品 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107737041A (zh) | 一种新型皮肤抗敏修护组合物、皮肤修复霜及其制备方法 | |
| KR101478945B1 (ko) | 자생 식물 및 천연 한약재 추출물을 함유한 샴푸 조성물 | |
| CN109303724A (zh) | 一种新型含艾叶的舒缓修护原液组合物 | |
| CN104434618B (zh) | 兼具美白、祛斑印功效的九草绿霜及其制备方法 | |
| CN103932970A (zh) | 一种中草药祛斑组合化妆品及其制备方法 | |
| CN109662928A (zh) | 一种具有防晒修复功效的护肤组合物及其应用和制备方法 | |
| CN105030621A (zh) | 一种保湿祛痘爽肤水及其制备方法 | |
| CN104784507A (zh) | 一种具有多重美容功效的中药组合物及其制备方法和应用 | |
| CN111617197A (zh) | 一种生发养发的中药组合物及其制备方法与应用 | |
| KR102026535B1 (ko) | 생약 추출 혼합물을 포함하는 화장료 조성물 | |
| KR100867514B1 (ko) | 지초 비누의 제조방법 | |
| KR101300701B1 (ko) | 아토피 피부용 화장품 제조방법 | |
| CN108670933B (zh) | 兼具保湿、美白、抗衰老的护肤组合物及其应用 | |
| CN104323961A (zh) | 一种美白祛斑中药面膜及其制备方法 | |
| CN108403589A (zh) | 天然植物护肤霜 | |
| CN105288597B (zh) | 一种治疗皮肤色素沉着的药物 | |
| CN114306410B (zh) | 一种紫草膏及其制备方法与应用 | |
| CN104116672A (zh) | 一种复方天然面膜及其制备方法 | |
| KR101764131B1 (ko) | 알로에 추출물 및 캡사이신을 유효성분으로 함유하는 피부 외용제 조성물 | |
| CN110787119A (zh) | 一种抗菌护肤中药组合物及其制备方法和应用 | |
| CN110179708A (zh) | 一种植物赋活精油及制备方法 | |
| CN109939193A (zh) | 一种治疗皮肤湿疹的组合物，制剂及制备方法和应用 | |
| CN105125467A (zh) | 一种祛红血丝乳液及其制备方法 | |
| KR101183893B1 (ko) | 아토피 피부염 개선능을 갖는 화장료 조성물 및 이의 사용방법 | |
| CN110680794A (zh) | 一种纯天然无化学添加剂的食品级珍珠蜂蜜茶味口腔护理组合物的绿色制备方法及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190205 |
|
| RJ01 | Rejection of invention patent application after publication |